Veracyte (VCYT) Equity Ratio: 2012-2025
Historic Equity Ratio for Veracyte (VCYT) over the last 12 years, with Sep 2025 value amounting to 0.92.
- Veracyte's Equity Ratio fell 0.31% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.92, marking a year-over-year decrease of 0.31%. This contributed to the annual value of 0.90 for FY2024, which is 3.41% down from last year.
- Per Veracyte's latest filing, its Equity Ratio stood at 0.92 for Q3 2025, which was up 1.21% from 0.91 recorded in Q2 2025.
- Veracyte's Equity Ratio's 5-year high stood at 0.95 during Q1 2021, with a 5-year trough of 0.90 in Q4 2024.
- Its 3-year average for Equity Ratio is 0.92, with a median of 0.92 in 2024.
- Per our database at Business Quant, Veracyte's Equity Ratio rose by 10.16% in 2021 and then fell by 3.41% in 2024.
- Over the past 5 years, Veracyte's Equity Ratio (Quarterly) stood at 0.92 in 2021, then rose by 0.72% to 0.93 in 2022, then rose by 0.72% to 0.94 in 2023, then dropped by 3.41% to 0.90 in 2024, then fell by 0.31% to 0.92 in 2025.
- Its last three reported values are 0.92 in Q3 2025, 0.91 for Q2 2025, and 0.91 during Q1 2025.